Sixteen-year-old Leah Carter was discharged from Canterbury’s Kent and Canterbury Hospital last month after a two-day battle with fever, vomiting, and a rash that doctors later confirmed as Meningitis B. Her symptoms emerged just days after her A-level exams ended. By the time antibiotics took effect, she had lost consciousness twice. "The doctors told me she’s lucky to be alive," said her mother, Sarah Carter. "But why wasn’t she protected by the vaccine everyone else got?"

Public Health England has privately confirmed a 35% surge in invasive MenB infections among 16-18-year-olds in the county this year compared to 2023. Yet the UK remains one of the few high-income nations where teenagers outside the infant vaccination program are excluded from free MenB jabs. The Joint Committee on Vaccination and Immunisation (JCVI) last reviewed the policy in 2019 and opted against extending coverage.

The JCVI’s decision hinged on cost-effectiveness calculations that placed the price of vaccinating all teens at £20 million annually. But new modelling shared exclusively with this newspaper shows that figure could drop to £13 million if the program phased in adolescents over five years. Dr. Priya Desai, a consultant epidemiologist at Public Health England, said: "The data we’re seeing now wasn’t available in 2019. The risk profile has shifted."

Leah Carter’s ordeal began with a headache that morphed into a purple rash within hours. Her GP initially dismissed it as a migraine. By the time paramedics arrived, her oxygen levels were critically low. She spent eight days in intensive care. "She’ll carry scars — physical and mental — for life," said Sarah Carter. "If the vaccine was offered at 14, she’d have had it."

Kent County Council’s director of public health, Dr. James Whitmore, has written to the Department of Health urging an emergency review. "The current policy is out of step with the lived reality of families in Kent," he said. Similar pleas have emerged from Surrey and Hampshire, where teen MenB cases have also climbed. The UK Health Security Agency has not yet responded to requests for comment.

Campaigners argue the delay is indefensible. Meningitis Now, a national charity, has collected over 50,000 signatures for a parliamentary petition demanding free MenB jabs for all 16-18-year-olds. "Every day we wait, more teenagers face lifelong consequences or death," said CEO Tom Nutt. The charity points to Italy, which introduced teen MenB vaccination in 2022 and saw cases drop by 40% in the first year.

1. Current UK Policy — Free MenB vaccine only for infants at 8 and 16 weeks, plus high-risk groups
2. Teen Gap — 16-18-year-olds excluded despite rising case rates
3. Cost Recalculation — New modelling shows £7M annual savings if phased approach adopted

The Department of Health has not indicated whether it will revisit the JCVI’s stance. Meanwhile, Leah Carter is back at school but struggles with fatigue and anxiety. "I just want other kids to be safe," she said. Her mother has joined the campaign for change. "No parent should have to watch their child fight for their life because a vaccine wasn’t offered."